SEC Form 4 · accession 0001209191-18-041768

Audentes Therapeutics, Inc. · BOLD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director

Period of report

Jul 2, 2018

Accepted (ET)

Jul 5, 2018 · 6:34 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001628738

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Jul 2, 2018	M	19,599	$0.78	A	19,599	D
Common Stock^F2	Jul 2, 2018	S	19,599	$38.3282	D	0	D
Common Stock	Jul 2, 2018	M	1,401	$0.78	A	1,401	D
Common Stock^F3	Jul 2, 2018	S	1,401	$38.7793	D	0	D
Common Stock	Jul 3, 2018	M	26,901	$0.78	A	26,901	D
Common Stock^F4	Jul 3, 2018	S	26,901	$40.0528	D	0	D
Common Stock	Jul 5, 2018	M	23,147	$0.78	A	23,147	D
Common Stock^F5	Jul 5, 2018	S	23,147	$40.042	D	0	D
Common Stock^F6	holding	—	—		—	171,814	I	By Matthew R. Patterson Revocable Trust

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F7	$0.78	Jul 2, 2018	M	19,599	D	—	Sep 25, 2023	Common Stock	19,599	159,151	D
Stock Option (right to buy)^F7	$0.78	Jul 2, 2018	M	1,401	D	—	Sep 25, 2023	Common Stock	1,401	157,750	D
Stock Option (right to buy)^F7	$0.78	Jul 3, 2018	M	26,901	D	—	Sep 25, 2023	Common Stock	26,901	130,849	D
Stock Option (right to buy)^F7	$0.78	Jul 5, 2018	M	23,147	D	—	Sep 25, 2023	Common Stock	23,147	107,702	D

F1This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
F2Represents the weighted average sale price. The lowest price at which shares were sold was $37.71 and the highest price at which shares were sold was $38.71. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes 2, 3, 4 and 5 to this Form 4.
F3Represents the weighted average sale price. The lowest price at which shares were sold was $38.72 and the highest price at which shares were sold was $38.99.
F4Represents the weighted average sale price. The lowest price at which shares were sold was $40.00 and the highest price at which shares were sold was $40.55.
F5Represents the weighted average sale price. The lowest price at which shares were sold was $40.00 and the highest price at which shares were sold was $40.17.
F6The reporting person is the trustee of the Matthew R. Patterson Revocable Trust.
F7The option vested as to 25% of the total shares on January 1, 2014, and then 6.25% of the total shares vest quarterly thereafter, with 100% of the total shares vested and exercisable on January 1, 2017, subject to the reporting person's provision of service to the issuer on each vesting date and to accelerated vesting in the event of the occurrence of certain events.